RadiotherapyRadiotherapy DosageRadiotherapy, AdjuvantChemotherapy, AdjuvantRadiotherapy, ConformalAdjuvants, ImmunologicCombined Modality TherapyRadiotherapy, Intensity-ModulatedRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyDose FractionationFreund's AdjuvantRadiation InjuriesRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedTreatment OutcomeNeoplasm Recurrence, LocalNeoplasm StagingRadiation OncologyAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalBreast NeoplasmsBrachytherapyRadiosurgeryDose-Response Relationship, RadiationAdjuvants, PharmaceuticHead and Neck NeoplasmsSurvival AnalysisSurvival RatePrognosisRetrospective StudiesFollow-Up StudiesChemoradiotherapyBrain NeoplasmsFluorouracilCarcinoma, Squamous CellNasopharyngeal NeoplasmsRectal NeoplasmsLung NeoplasmsCisplatinRadiation ToleranceTime FactorsOrgans at RiskRadiation-Sensitizing AgentsSubcellular FractionsAntineoplastic AgentsParticle AcceleratorsMastectomy, SegmentalCranial IrradiationNeoadjuvant TherapyProstatic NeoplasmsRadiometryRadiation DosageAdenocarcinomaLymphatic MetastasisCyclophosphamideVincristineRadiation PneumonitisDacarbazineNeoplasms, Second PrimaryPelvic NeoplasmsLaryngeal NeoplasmsRadiodermatitisTomography, X-Ray ComputedAntineoplastic Agents, HormonalNeoplasmsHodgkin DiseaseKaplan-Meier EstimateMastectomyDoxorubicinNeoplasms, Radiation-InducedHeavy Ion RadiotherapyProcarbazineProspective StudiesOrgan Sparing TreatmentsAluminum HydroxideCarcinoma, Non-Small-Cell LungTamoxifenCarcinomaXerostomiaDrug Administration ScheduleRadioisotope TeletherapyPalliative CareSpinal NeoplasmsGlioblastomaAntineoplastic Agents, AlkylatingLymphatic IrradiationSarcomaMethotrexateUterine Cervical NeoplasmsCobalt RadioisotopesMice, Inbred BALB CImmunizationNeoplasm MetastasisProportional Hazards ModelsMechlorethamineRadiation-Protective AgentsSalvage TherapyVinblastineBleomycin